Drugs / Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06314685 | Dec 2021 → Aug 2024 | — | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06314685 ↗ |
| Modality | Vaccine | “As a experimental vaccine for 6 months to 5 years old.” NCT06314685 ↗ |